Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 10, 2021

SELL
$249.67 - $299.48 $1.31 Million - $1.57 Million
-5,258 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$222.0 - $252.62 $246,864 - $280,913
1,112 Added 26.82%
5,258 $1.31 Million
Q3 2020

Nov 12, 2020

SELL
$175.56 - $226.45 $340,586 - $439,313
-1,940 Reduced 31.88%
4,146 $939,000
Q2 2020

Aug 14, 2020

BUY
$118.84 - $189.72 $723,260 - $1.15 Million
6,086 New
6,086 $1.06 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.38B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Intrepid Capital Management Inc Portfolio

Follow Intrepid Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intrepid Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Intrepid Capital Management Inc with notifications on news.